Fluoropharma Medical Stock Today
| FPMI Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Fluoropharma Medical is trading at 1.0E-4 as of the 28th of November 2024. This is a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Fluoropharma Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Fluoropharma Medical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with initial applications in the area of cardiology in the United States. FluoroPharma Medical, Inc. The company has 34.26 M outstanding shares. More on Fluoropharma Medical
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Fluoropharma Pink Sheet Highlights
| CEO and President and Director | Thomas Tulip |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Fluoropharma Medical [FPMI] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fluoropharma Medical's market, we take the total number of its shares issued and multiply it by Fluoropharma Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fluoropharma Medical conducts business under Biotechnology sector and is part of Health Care industry. The entity has 34.26 M outstanding shares.
Fluoropharma Medical currently holds about 24.72 K in cash with (880.12 K) of positive cash flow from operations.
Check Fluoropharma Medical Probability Of Bankruptcy
Ownership AllocationFluoropharma Medical holds a total of 34.26 Million outstanding shares. Roughly 99.66 percent of Fluoropharma Medical outstanding shares are held by general public with 0.34 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Fluoropharma Ownership Details
Fluoropharma Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fluoropharma Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Fluoropharma Medical Corporate Executives
Elected by the shareholders, the Fluoropharma Medical's board of directors comprises two types of representatives: Fluoropharma Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluoropharma. The board's role is to monitor Fluoropharma Medical's management team and ensure that shareholders' interests are well served. Fluoropharma Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluoropharma Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tamara Rhein | CFO and Principal Accounting Officer | Profile |
Other Information on Investing in Fluoropharma Pink Sheet
Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.